When the receiver operating characteristic (ROC) curve was used to analyze the diagnostic profile of TM4SF18 for GC, the area under the ROC curve was found to be 0.786 (Fig. 1J), suggesting that TM4SF18 has good diagnostic efficacy. Here, TM4SF18 is linked to gastric cancer.